A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers

Clinical trial NCT02382666 · COMPLETED

Trial details

NCT number: NCT02382666
Sponsor: Tesaro, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2015-01-01
Primary completion: 2015-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.